The lack of early-stage capital and de-risking support is a major challenge in advancing promising biomedical technologies from research labs to commercial partners. Federal agencies are stepping up to support innovators who take on the hardest challenges in emerging, transformative biomedical and health technologies. In this funding environment, start-up companies are increasingly looking to bridge the “valley of death” with federal in-kind resources and funding. Likewise, academic accelerator programs and gap funds are also looking for federal partnerships to support de-risking efforts.
The All-Federal panel will provide the audience with a guided tour of their respective agency programs. Each panelist will provide a briefing of how their program is positioned to partner with stakeholders, and educate the audience on upcoming funding opportunities.
